Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CSPC Pharmaceutical Group ( (HK:1093) ) has shared an announcement.
CSPC Pharmaceutical Group Limited has announced the signing of new lease agreements as the previous ones are set to expire in June 2025. The new agreements involve several subsidiaries of the company and are structured as connected transactions under Hong Kong’s Listing Rules. These agreements, which extend the leases for various premises for three years, are subject to certain reporting and announcement requirements, reflecting the company’s ongoing operational adjustments and compliance with regulatory standards.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. The company is involved in the production and distribution of pharmaceutical products and services, with a focus on various healthcare needs.
Average Trading Volume: 215,527,575
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$87.63B
For detailed information about 1093 stock, go to TipRanks’ Stock Analysis page.